Omnicell (OMCL) vs Privia Health Group (PRVA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Omnicell (OMCL) has outperformed Privia Health Group (PRVA) over the past year, gaining 16.4% versus a loss of 15.5%. Over five years, PRVA leads with a -13.7% price change compared with -77.7% for OMCL. Privia Health Group is the larger company by market cap ($2.59 billion vs $1.60 billion), about 1.6 times the size.
On valuation, Omnicell trades at a lower forward P/E (16.8x vs 19.1x for Privia Health Group).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OMCL | PRVA |
|---|---|---|
| Share price | $35.21 | $20.30 |
| Market cap | $1.60B | $2.59B |
| 1-day change | -0.71% | +0.10% |
| YTD return | -22.27% | -14.38% |
| 1-year return | +16.40% | -15.45% |
| 5-year return | -77.71% | -13.65% |
| P/E ratio (TTM) | 41.92 | 96.67 |
| Forward P/E | 16.85 | 19.13 |
| EPS (TTM) | $0.84 | $0.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $55.00 | $28.82 |
| 52-week low | $29.06 | $18.92 |
| Distance from 52-week high | -35.98% | -29.56% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +64.33% | +55.02% |
| Average volume | 677.88K | 1.23M |
| Shares outstanding | 45.48M | 127.73M |
| Employees | 3,485 | 1,226 |
| Sector | Technology | Health Care |
| Industry | Computer Manufacturing | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OMCL has outperformed PRVA by 31.8 percentage points over the past year.
- Privia Health Group trades at a higher earnings multiple (96.7x vs 41.9x trailing P/E).
- The two companies sit in different sectors: Omnicell in Technology and Privia Health Group in Health Care.
About Omnicell
OMCL stock →Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process.
Technology · Computer Manufacturing · 3,485 employees
About Privia Health Group
PRVA stock →Privia Health Group, Inc. operates as a national physician-enablement company in the United States.
Health Care · Medical/Nursing Services · 1,226 employees
OMCL vs PRVA FAQ
Which is bigger, Omnicell or Privia Health Group?
Privia Health Group (PRVA) is larger, with a market capitalization of $2.59B compared with $1.60B for Omnicell (OMCL).
Which stock has performed better over the past year, OMCL or PRVA?
OMCL returned +16.40% over the past 12 months, compared with -15.45% for PRVA (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, OMCL or PRVA?
OMCL has the lower trailing P/E at 41.9, versus 96.7 for PRVA. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Omnicell and Privia Health Group in the same industry?
No. Omnicell is in the Technology sector, while Privia Health Group is in Health Care.